Data / Form D filings / New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc.: Form D filings
New Haven Pharmaceuticals, Inc., a pharmaceuticals company in North Haven, CT, filed 3 Form D notices with the SEC between 2012 and 2016. The latest, on August 17, 2016, reports $602,222 sold of a $1.3 million offering to 3 investors.
Find out what New Haven Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 116 WASHINGTON AVENUE, 4TH FLOOR, North Haven, CT, 06473
- Phone
- (203) 676-3676
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1558788
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2016 | New notice | $1,301,736 | $602,222 | $699,514 | 3 | Aug 1, 2016 | sec.gov |
| Oct 23, 2014 | New notice | $21,770,161 | $11,786,611 | $9,983,550 | 9 | Oct 8, 2014 | sec.gov |
| Oct 2, 2012 | New notice | $7,706,688 | $6,490,773 | $1,215,915 | 17 | Sep 19, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harry H. Penner, Jr. | Executive Officer, Director | |
| Christopher H. Ecklund | Director | |
| Theodore H. Stanley | Director | |
| William H. Sessa | Director | |
| Daniel H. Wagner | Director | |
| Larry H. Dillaha | Director | |
| Patrick H. Fourteau | Executive Officer, Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Aug 15, 2016 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what New Haven Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.